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Abstract
Background: Quality of life (QOL) is important to patients with end stage renal disease and their partners. Despite
the first 12 weeks being a critical time in the treatment pathway, limited research exists which examines how the
transition onto dialysis impacts QOL. In this study we measured QOL in patients and their partners at pre-dialysis
and over the first 12 weeks on dialysis to investigate QOL during this crucial period.
Methods: Patients and their partners, recruited from 10 renal units in England, completed questionnaires at pre-
dialysis (n = 166 participants, 83 couples), 6 weeks (n = 90 participants, 45 couples) and 12 weeks (n = 78, 39 couples)
after starting dialysis. On each occasion participants completed a QOL questionnaire (WHOQOL-BREF). Multilevel
modelling accommodated the nested structure of couples with repeated measures within participants. Three-level
random intercept models estimated changes in WHOQOL general QOL and its four domains (Physical,
Psychological, Social and Environment). Two-level random intercept models assessed the relationship between
baseline clinical and socio-demographic variables with changes in general QOL.
Results: Patients reported positive changes in general QOL from pre-dialysis to 6 weeks (β = 0.42, p < 0.001, 95% CI
0.19, 0.65) and from pre-dialysis to 12 weeks (β = 0.47, p < 0.001, 95% CI 0.24, 0.71). Partners’ general QOL decreased
significantly from pre-dialysis to 6 weeks (β = − 0.24, p = 0.04, 95% CI -0.47, − 0.01) but returned to its original level
at 12 weeks. Patients reported improvements in the physical domain between pre-dialysis and 12 weeks (β = 6.56,
p < 0.004, 95% CI 2.10, 11.03). No other domains changed significantly in patients or partners. Only in patients were
there significant associations between moderator variables and general QOL. High comorbidity risk level and
diabetes were associated with poorer QOL at pre-dialysis whereas being female and having an arteriovenous fistula
were linked with improvements in general QOL.
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Conclusions: Patients reported significant improvements in their general and physical QOL after starting dialysis.
Partners’ general QOL worsened after patients started dialysis but improved by 12 weeks. Both patients and partners
may benefit from additional educational and counselling services in the lead up to, and immediately after starting
dialysis, which could facilitate the transition onto dialysis and improve QOL in both.
Study registration: This study was adopted on the NIHR Clinical Research Network (UK). The details of this study
are registered on the Research Registry website (www.researchregistry.com). The identifier for this study is
researchregistry2574.
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Background
When preparing to start dialysis, patients with end stage
renal disease (ESRD) and their primary caregivers (part-
ners) consistently state that quality of life (QOL) is an
important concern [1–3]. Quality of life (QOL) is de-
fined by the World Health Organization [4] as “an indi-
vidual’s perception of their position in life in the context
of the culture and value systems in which they live, and
in relation to their goals, expectations, standards and
concerns” (p. 43). This definition complements the ESRD
illness trajectory of dialysis patients, as described by
Jablonski [5], which indicates that changes occur in all
areas of patients’ lives as they start and initially adjust to
dialysis, referred to as the “crisis” phase (p. 54). Psycho-
social interventions delivered in the critical first 12
weeks have been linked with better adjustment and de-
creased levels of depression in patients [6]. Despite gen-
eral well-being linked to better compliance, attendance
of dialysis sessions and adjustment [7], research primar-
ily focuses on patient survival or hospitalization rates ra-
ther than examining QOL [8, 9]. Although playing a key
role in patients’ dialysis care [10, 11], little is known
about how partners’ QOL is affected during the crisis
phase.
Quality of life is a broad field with a multitude of
scales to measure QOL and factors relating to it. Al-
though patients and partners state QOL is a primary
concern, it is not included as a core outcome measure in
ESRD randomized control trials due to a lack of consen-
sus on how best to define and measurement it [12].
Therefore, ESRD research may benefit from using a gen-
eric QOL measure which directly addresses QOL, rather
than ESRD-specific or health status measures, and as-
sesses several areas related to QOL (e.g., physical and
emotional health, social support). One such measure is
the World Health Organization’s WHOQOL-BREF short
questionnaire [13] which was created by an international
collaboration using an inductively-driven process, with
the specific aim of designing a scale to measure QOL
across all types of chronic illnesses and healthy people
[14]. It includes a general QOL facet covering overall
QOL and health and four QOL domains, physical, psy-
chological, social and environment. Furthermore, pa-
tients who use haemodialysis (HD) and peritoneal
dialysis (PD) and their partners have outlined energy, fa-
tigue, ability to travel, work, and sleep [15, 16] as out-
comes important to them, all of which are assessed in
the WHOQOL-BREF.
Qualitative research including patients with ESRD and
their partners suggests that they experience significant
lifestyle changes as they adjust to dialysis [17–19] which
impacts important areas of their QOL [20]. Our recent
research with patients in the early phases of dialysis (i.e.,
pre-dialysis or on dialysis < 15months) and their part-
ners found that couples who adopted a team-like
approach minimized the impact of dialysis on their rela-
tionship, and ultimately their QOL [17]. The findings of
this study also suggest that starting dialysis affects pa-
tients and partners differently. For example, patients
spoke of dialysis alleviating their worries and improving
their health whereas partners reported an increase in
burdens and significant changes in their personal lives.
To date, only one longitudinal study has examined
how health status in both patients and partners
changes after the start of dialysis. Fan et al. [21] con-
ducted a single-centre study with patients on PD and
their partners. Both completed the Medical Outcomes
Study 36-Item Short Form Survey (SF-36), which
measures various components of physical (PCS) and
mental functioning (MCS), before the patient started
PD and then again 1 year later. Before starting PD,
PCS and MCS scores for both were lower than those
of the general population. At 1 year, PCS and MCS
scores improved modestly, and the social functioning
subscale of the MCS showed statistically significant
improvements in patients and partners. It remains un-
clear how starting dialysis impacts patients and their
partners on other types of dialysis (e.g., HD). Further
research is needed to examine the critical first 12
weeks and investigate QOL in its broader conceptual-
isation, rather than focusing on functioning as mea-
sured by the SF-36.
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The aim of this study was to assess changes in QOL in
patients and their partners, measured by the WHOQOL-
BREF, during the crucial transition onto dialysis, from
pre-dialysis to 12 weeks after starting dialysis. The primary
goal was to describe QOL changes in WHOQOL general
QOL and its domains over this transition period, in both
patients and their partners. We also sought to examine
whether starting dialysis affects patients’ and their part-
ners’ QOL differently. We predicted that patients would
report improvements in general QOL at 12 weeks, and
their partners’ QOL would steadily worsen. Additionally,
we examined whether clinical and socio-demographic fac-
tors were associated with changes in QOL.
Methods
Study design and setting
We used a multi-centre, longitudinal design to study
changes in QOL in couples in which one person was
starting dialysis. To closely examine the transition onto
dialysis, both members of the couple - the patient and
their partner - completed the study measures on three
occasions: baseline (pre-dialysis) and two follow-ups (6
weeks and 12 weeks after starting dialysis). The study
was adopted onto the National Institute for Health Re-
search (NIHR) Clinical Research Portfolio (CPMS ID
35781) and conducted with 10 renal units across
England.
Study participants
Participants were recruited from November 2017–Sep-
tember 2018. Renal research nurses or members of the
clinical care teams identified potential participants from
their renal registries. Patients meeting the following cri-
teria were eligible to participate: 1) they were in the care
of a nephrologist for ESRD, including patients who were
starting dialysis in an unplanned manner (i.e., people
who had been under the care of nephrologists for less
than 3 months before commencing dialysis), 2) their
clinical factors indicated that they were likely to start
dialysis in the next 2 months (i.e., their clinical care team
assessed the longitudinal trend of their estimated glom-
erular filtration rate [eGFR, an indicator of how well the
kidneys are eliminating toxins; calculated using the CKD
EPI equation in the UK], symptom burden, serum albu-
min, haemoglobin, and patient preference, in accordance
with the UK’s NICE guidance on dialysis initiation), 3)
they were planning to receive a form of out-patient dia-
lysis for the management of ESRD, including all forms of
HD and PD, 4) they were in a spousal-type relationship
with someone they considered their “partner,” and 5)
they were 18 years or older. Incident patients (i.e., those
who had not been on a form of renal replacement ther-
apy before) and patients who had a failing transplant
and were planning to start dialysis, but had not been on
any form of out-patient dialysis in the last 6 months,
were included. Patients were not eligible for the study if
they had acute kidney injuries or were receiving long-
term inpatient dialysis for other health conditions.
A partner was defined as a person in a spousal-type re-
lationship who provided informal care in the form of
emotional, physical and/or treatment-related support to
an eligible patient [22]. Partners either self-identified as
the patient’s partner or were identified as such by the
patient. Inclusion criteria for partners were that they
were in a spousal-type relationship (e.g., spouse, partner,
boyfriend, or girlfriend) with the patient and were 18
years or older. Both patients and partners needed to be
able to read and comprehend English.
Procedure
Those meeting the inclusion criteria were invited to par-
ticipate by the site investigator (SI). If the SI was not
part of the patient’s clinical care team, a member of the
clinical care team obtained the patient’s consent to con-
tact before the SI approached the patient. The SI gave
potential participants a letter of invitation and informa-
tion sheet and provided further information about the
study. Participation in the study was voluntary, and all
recruited participants gave their written informed con-
sent prior to taking part. This study only included cou-
ples in which both patients and their partners consented
to participate and where both returned baseline ques-
tionnaires. At the follow-ups, all data from patients and
partners were included, even if one member of the
couple did not complete the questionnaire.
Before administering the questionnaires, the SI
reminded participants that the questions ask about their
QOL, health and their thoughts about dialysis and pro-
vided them with paper-versions of the questionnaires, ei-
ther directly at a clinical appointment or via the post.
Patients and partners completed similar versions of the
questionnaires at each assessment and were requested
not to confer. Patients and partners completed the ques-
tionnaires at home (95%) or in the renal unit (5%). Only
three (2%) requested the SI read the questionnaire aloud;
SIs were trained to administer the questionnaires in a
standard manner.
Measures
Quality of life was assessed using the WHOQOL-BREF
[13]. This instrument reflects a multi-dimensional model
of subjective QOL in health and is assessed by 26 ques-
tions. Two questions (items) form the WHOQOL gen-
eral QOL facet and 24 specific items are scored in one
of four domains: physical, psychological, social relation-
ship, and environmental QOL. Participants assess their
QOL over the last 2 weeks and rate responses to each
item on a five-point Likert interval scale, where higher
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scores indicate better QOL. The primary outcome vari-
able in the present study was WHOQOL general QOL,
which is the mean of the overall QOL item (How would
you rate your quality of life? 1 = Very poor, 2 = Poor, 3 =
Neither good nor poor, 4 = Good, 5 = Very good) and
the health-related QOL item (How satisfied are you with
your health? 1 = Very dissatisfied, 2 = Dissatisfied, 3 =
Neither satisfied or dissatisfied, 4 = Satisfied, 5 = Very
satisfied) with a scoring range of 1–5. A score of 3 indi-
cates moderate QOL, or QOL that is okay. A score less
than 3 is commonly regarded as indicating poor or very
poor QOL. Scores greater than 3 indicate good to very
good QOL. The WHOQOL-BREF domain scores were
transformed onto a scale from 0 to 100 to facilitate com-
parisons between different domains with unequal item
numbers. Domain scores less than 50 indicate poor or
very poor QOL. This instrument has been validated in
both well [14] and dialysis populations [23] and shows
good internal consistency and construct validity [13].
Furthermore, it has been found to be fairly sensitive to
change across health conditions [24, 25].
Additionally, participants completed questionnaires on
key factors related to QOL, namely dialysis expectations,
accepting dialysis, patient-partner relationship character-
istics, anxiety, depression, and symptoms. Descriptive
statistics of these variables are included in Table 1 but
will not be discussed further.
Socio-demographic information on gender, age, rela-
tionship status, ethnicity, employment status, and high-
est educational level attained was self-reported at pre-
dialysis. At the follow-ups, patients self-reported any
changes in their dialysis treatment including mode of
dialysis, access site (i.e., how they connected to their dia-
lysis machine, e.g., catheter, fistula), renal unit, and if
they had been hospitalized. Clinical data were collected
from patients’ medical records by the SI in each renal
unit at each time point. Clinical data included eGFR
(baseline only), haemoglobin, serum albumin, dialysis
adequacy (follow-ups only), comorbidities, primary renal
diagnosis (PRD), and dialysis information (type of access:
arteriovenous fistula [AVF], tesio line, PD catheter;
mode of dialysis; start of dialysis: unplanned or planned;
patient type: incident or prevalent; dialysis prescription;
and dialysis status 3 months and 6months after partici-
pating). Patients’ comorbidity data were scored following
the guidelines of Davies et al. [26]. In this scoring
method, active comorbidities are classified into one of
seven domains (malignancy, ischaemic heart disease,
peripheral vascular disease, left ventricular dysfunction,
diabetes mellitus, systemic collagen vascular disease, and
other significant pathology), and the patient’s comorbid
risk level is attained by adding the number of domains
affected (scoring range for risk 0–7: 0 = low, 1–2 =
medium, ≥3 = high).
Statistical analysis
Missing data were reviewed and descriptive statistics
(means, standard deviations, percentages) were calcu-
lated for the QOL, socio-demographic and clinical vari-
ables. To determine if differences existed between
participants who did and did not complete the study, t-
tests were used for continuous variables and chi-squared
for categorical variables.
Multilevel modelling (MLM) provides a robust yet
flexible framework to estimate changes over time in
nested structures, such as individuals within couples.
Multilevel models estimated using maximum likelihood
can accommodate missing data unlike ANOVA based
methods which drop observations using listwise deletion
[27]. In the context of repeated measures, this means
that all available data for an individual will be used in es-
timating the model, rather than reducing the dataset to
complete cases only.
For the present data structure, of repeated observa-
tions within individuals, nested within a social group
(e.g., couple), a three-level mixed effects linear regression
with random intercepts was used to estimate changes in
WHOQOL general QOL. The MLM equation used for
calculating the changes between groups (patients and
partners) and over the follow-ups (F1 = pre-dialysis to 6
weeks, F2 = pre-dialysis to 12 weeks):
QOL ¼ β0 þ β1Groupþ β2F1þ β3F2þ β4GroupF1
þ β5GroupF2þ uþ vþ e
Then, a linear combination of parameters was used to
examine whether partners’ QOL changed significantly
from pre-dialysis to 6 weeks and pre-dialysis to 12 weeks.
To aid in the interpretation of these interactions, the re-
sults of the models will also be displayed graphically
using marginal mean plots to illustrate the models’ re-
gression coefficients.
To analyse changes in the WHOQOL domains, the
above equation and sequence was replicated for each do-
main by replacing the general QOL outcome variable
with the transformed domain scores in each model.
To examine the association of baseline clinical and socio-
demographic variables with changes in WHOQOL general
QOL, separate two-level models for patients and partners
with the interaction for time were conducted for each vari-
able (Patients: haemoglobin, eGFR, serum albumin, mode
of dialysis, type of patient, start of dialysis, access type in pa-
tients planning to start HD, PRD, comorbidity risk, gender,
and age; Partners: gender and age):
QOLij ¼ β0 þ β1X j þ β2F1ij þ β3F2ij þ β4X jF1ij
þ β5X jF2ij þ v j þ eij
Paired sample t-tests were used to examine the differ-
ences in patients' scores over time within the facets of
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Male n (%)^ 52 (63%) 26 (59%) 26 (67%) 0.51 31 (37%) 18 (41%) 13 (33%) 0.51
Age M (SD, years) 64 (14) 64 (14) 64 (14) 0.82 63 (15) 64 (15) 62 (15) 0.72




None 4 (5%) 3 (7%) 1 (3%) 4 (5%) 3 (7%) 1 (3%)
Primary school 3 (4%) 2 (5%) 1 (3%) 2 (2%) 1 (2%) 1 (3%)
Secondary school 40 (48%) 19 (43%) 21 (55%) 33 (40%) 18 (41%) 15 (38%)
College or training
certification
25 (30%) 15 (34%) 10 (26%) 36 (43%) 18 (41%) 18 (46%)
University –
undergraduate
4 (5%) 3 (7%) 1 (3%) 5 (6%) 3 (7%) 2 (5%)
University –
postgraduate
6 (7%) 2 (5%) 4 (11%) 3 (4%) 1 (2%) 2 (5%)
Missing 1 (1%) 0 (0%) 1 (3%) – – –
Ethnicity n (%)*^ 3.72 3.73
White British 75 (91%) 38 (87%) 37 (94%) 77 (93%) 39 (89%) 38 (97%)
White Other 1 (1%) 1 (2%) 0 (0%) 1 (1%) 1 (2%) 0 (0%)
Asian Pakistani 2 (2%) 1 (2%) 1 (3%) 2 (2%) 1 (2%) 1 (3%)
Asian Other 3 (4%) 3 (7%) 0 (0%) 2 (2%) 2 (5%) 0 (0%)
Mixed/Multiple ethnic
groups
– – – 1 (1%) 1 (2%) 0 (0%)




Retired 44 (53%) 23 (52%) 21 (55%) 45 (54%) 23 (52%) 22 (56%)
Working full-time 20 (24%) 10 (23%) 10 (26%) 15 (18%) 7 (16%) 8 (21%)
Working part-time 5 (6%) 3 (7%) 2 (5%) 10 (12%) 6 (14%) 4 (10%)
Unable to work 12 (14%) 7 (16%) 5 (13%) 6 (7%) 3 (7%) 3 (8%)
Do not work – – – 6 (7%) 4 (9%) 2 (5%)
Missing 2 (2%) 1 (2%) 1 (3%) 1 (1%) 1 (2%) 0 (0%)
Dialysis characteristics
Type of patient n (%)^ 1.53
Incident patient 54 (65%) 28 (64%) 26 (67%) – – –
Prevalent patient 6 (7%) 2 (4%) 4 (10%) – – –
Missing 23 (28%) 14 (32%) 9 (23%) – – –
Start of dialysis^ 10.30
Planned 52 (63%) 22 (50%) 30 (77%) – – –
Unplanned 4 (5%) 1 (2%) 3 (8%) – – –
Missing 27 (32%) 21 (48%) 6 (15%) – – –
Mode of dialysis n (%)^ 1.76
HD 50 (60%) 29 (66%) 21 (54%) – – –
PD 24 (29%) 10 (23%) 14 (36%) – – –
Missing 9 (11%) 5 (11%) 4 (10%) – – –
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Type of access at pre-dialysis n (%)^ 11.69
AVF 27 (33%) 12 (27%) 15 (38%) – – –
Tesio line 7 (8%) 3 (7%) 4 (10%) – – –
PD catheter 21 (25%) 7 (16%) 14 (36%) – – –
Missing 28 (34%) 22 (50%) 6 (16%) – – –
Clinical variables





109.9 (15.2) 105.8 (16.6) 0.27 – – –
Serum albumin g/LM
(SD)
37.9 (6.0) 39.0 (6.3) 36.7 (5.5) 0.10 – – –
Comorbidity risk n (%)^ 2.25
Low 23 (28%) 12 (27%) 11 (28%) – – –
Medium 42 (50%) 20 (45%) 22 (56%) – – –
High 10 (12%) 6 (14%) 4 (10%) – – –
Missing 8 (10%) 6 (14%) 2 (5%)
Primary renal diagnosis n
(%)^
8.70
Glomerulonephritis 10 (12%) 5 (11%) 2 (13%) – – –
Polycystic 9 (11%) 6 (14%) 3 (8%) – – –
Diabetes 7 (8%) 4 (9%) 3 (8%) – – –
Renal vascular disease 5 (6%) 4 (9%) 1 (3%) – – –
Hypertension 4 (5%) 2 (5%) 2 (5%) – – –
Pyelonephritis 3 (4%) 3 (7%) 0 (0%) – – –
Other 4 (5%) 3 (7%) 1 (3%) – – –
Uncertain 7 (8%) 4 (9%) 3 (8%) – – –
Missing 34 (41%) 13 (30%) 21 (54%)
Quality of life
WHOQOL General QOL 2.8 (0.9) 2.8 (0.9) 2.8 (0.8) 0.94 3.5 (0.9) 3.5 (0.9) 3.6 (0.9) 0.47
WHOQOL Physical 46.4 (21.9) 44.46 (23.1) 48.3 (20.7) 0.44 67.3 (21.3) 66.0 (21.1) 68.7 (21.6) 0.58
WHOQOL Psychological 61.7 (18.6) 60.1 (17.4) 63.2 (19.9) 0.48 66.0 (18.6) 64.5 (19.1) 67.5 (18.2) 0.50
WHOQOL Social 63.2 (21.1) 61.2 (20.6) 65.3 (21.7) 0.40 64.8 (16.7) 62.3 (18.3) 67.4 (14.6) 0.18
WHOQOL Environmental 67.4 (15.1) 65.6 (14.6) 69.2 (15.6) 0.29 67.8 (15.9) 65.0 (15.2) 70.8 (16.2) 0.11
Psychological and relationship variables
HADS Anxiety 6.9 (4.3) 7.1 (4.3) 6.7 (4.3) 0.73 7.1 (4.0) 6.4 (3.8) 7.8 (4.2) 0.13
HADS Depression 6.8 (4.2) 6.9 (4.3) 6.7 (4.1) 0.83 5.1 (4.1) 5.4 (4.3) 4.7 (3.9) 0.46
Dialysis expectations 3.3 (0.7) 3.3 (0.7) 3.4 (0.7) 0.62 3.2 (0.5) 3.1 (0.4) 3.2 (0.6) 0.46
Accepting dialysis 3.3 (0.6) 3.3 (0.6) 3.3 (0.6) 0.82 3.4 (0.7) 3.4 (0.6) 3.4 (0.7) 0.71
Dyadic relationship
characteristics
3.9 (0.6) 4.1 (0.6) 3.8 (0.7) 0.09 3.8 (0.6) 3.9 (0.6) 3.7 (0.5) 0.13
Relationship satisfaction 4.4 (0.9) 4.4 (0.9) 4.5 (0.9) 0.79 4.4 (0.7) 4.3 (0.8) 4.4 (0.7) 0.71
Symptoms
Symptom severity 20.9 (11.5) 22.1 (13.3) 19.8 (9.5) 0.39 9.3 (8.7) 9.2 (9.1) 9.3 (8.4) 0.97
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the WHOQOL physical domain at pre-dialysis and 12
weeks. A p-value of < 0.05 was considered significant.
All statistical analyses were conducted using Stata (Ver-
sion 15.1, Stata Corp, College Station, Texas, USA).
Results
Questionnaire characteristics
Missing data on the WHOQOL-BREF were minimal at
each time point in the WHOQOL general QOL facet
(pre-dialysis (T1): 2%, 6 weeks (T2): 2%, 12 weeks (T3):
0%) and across items of the four WHOQOL domains
(T1: 11%, T2: 4%, T3: 4%). An exception was the item
‘How satisfied are you with your sex life?’ which had a
higher percentage of missing data (T1: 11%, T2: 11%,
T3: 15%). Questionnaires with > 20% missing data across
the 26 items were not included in the analysis (T1: 6%,
T2: 0%, T3: 0%). WHOQOL general QOL and its do-
main scores were only calculated if 80% of the items
comprising it were completed.
Participant characteristics
Of the 153 patients invited to join the study, 91 (59%)
consented. Reasons given for not participating were: the
patient or partner did not feel well enough (n = 12), too
busy to take part (n = 8), patient started dialysis before
informed consent and the first questionnaire completed
(n = 4), partner not interested in participating (n = 3), pa-
tient waiting to receive a transplant (n = 1), found the
questions too intrusive (n = 1), and reason not offered
(n = 25). Of the 88 couples who both consented, 83 cou-
ples returned their baseline questionnaires. Significant
drop out (n = 38 couples, 46%) occurred from pre-
dialysis to 6 weeks with 45 couples providing data at 6
weeks. Between the 6 and 12-week follow-up, a further 6
couples (14%) dropped out so that a total of 39 couples
provided data across the study time points (see Fig. 1).
Comparisons between participants who completed the
study and those who dropped out before follow-ups
indicated minimal differences between these groups in
terms of baseline socio-demographic, dialysis, clinical,
QOL, psychological, relationship, or symptom variables.
However, patients who only participated at baseline had
a higher eGFR than those who completed the study
(10.0 ± 4.0 vs 8.5 ± 2.2, p = 0.04). These baseline charac-
teristics are provided in Table 1. Additionally, raw
means and standard deviations of WHOQOL-BREF
scores for patients and partners at baseline and the
follow-ups are provided in Table 2.
At 6 weeks after starting dialysis, 22 (49%) patients
had begun conventional HD (4 h three times per week;
standard UK guidelines), 13 (29%) were on PD, 1 (2%)
used HD for 2 h twice per week, and for 9 (20%) patients
their dialysis prescription was missing. Between pre-
dialysis and the 6-week follow-up, 15 patients had
moved to a new renal unit, 3 changed their type of ac-
cess, 2 changed their dialysis mode, and 13 were hospi-
talized since starting dialysis. Between the 6 week and
12 weeks, 4 patients moved renal units, 2 changed their
access types, 4 changed dialysis mode, and 4 were hospi-
talized. Mean dialysis adequacy was 1.45 ± 0.47 at 6
weeks and 1.38 ± 0.36 at 12 weeks; however, there was
considerable missing data (T2: 32%, T3:69%).
The sample contained 166 participants at baseline, 90
at 6 weeks, and 78 at 12 weeks. This sample size enabled
80% power to detect a medium effect (F = 0.32) of
changes in WHOQOL general and its domains, from
pre-dialysis to each follow-up. Residuals were assessed
and normally distributed in each of the random-effects
models.
Changes in WHOQOL general QOL
Patients
Patients reported their general QOL as poor at pre-
dialysis. At 6 weeks, patients’ QOL improved from poor
to good (β = 0.42, p < 0.001, 95% CI 0.19, 0.65) with a
slight further improvement at 12 weeks (β = 0.47, p <



















Number of symptoms 9.3 (4.2) 9.0 (4.8) 9.5 (3.6) 0.58 4.8 (3.6) 4.4 (3.8) 5.2 (3.4) 0.29
Note. AVF arteriovenous fistula, HADS Hospital Anxiety and Depression Scale, HD haemodialysis, PD peritoneal dialysis, eGFR estimated glomerular filtration rate,
QOL quality of life, WHOQOL World Health Organization’s Quality of Life Short Form (BREF). Incident patient means a patient starting dialysis for the first time;
prevalent refers to a patient who has been on a form of renal replacement therapy before but who intends to start dialysis due to a failing transplant. QOL was
measured using the WHOQOL-BREF with scoring range of 1–5 for General QOL and 1–100 for its four domains. Anxiety and depression were assessed using the
HADS, scoring range 0–21. Dialysis expectations, accepting dialysis, dyadic relationship characteristics and relationship satisfaction were assessed using study
specific measures designed by the research team, each with a scoring range of 1–5. Symptoms were measured using the Palliative care Outcomes Scale –
Symptoms (POS-S). Patients completed the renal version (17 items, severity symptom score range 0–68), and partners completed the general version (14 items,
severity symptom score range 0–56). High scores on the WHOQOL-BREF indicate good QOL. High scores on dialysis expectations, accepting dialysis, DRC and
relationship satisfaction suggest high expectations of dialysis, being accepting of dialysis, cohesive relationships characteristics between patients and partners, and
satisfaction in the couple’s relationship. High scores on the HADS and POS-S suggest the presence of anxiety, depression and high symptom burden
* Ethnicity codes taken from those used in UK renal units
^ Chi-squared
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Fig. 1 Flow chart showing recruitment and retention
Table 2 WHOQOL-BREF scores for patients and partners, raw mean (SD)
Patients Partners
Pre-dialysis 6 weeks 12 weeks Pre-dialysis 6 weeks 12 weeks
n = 83 n = 45 n = 39 n = 83 n = 45 n = 39
WHOQOL General QOL 2.8 (.9) 3.2 (.9) 3.3 (.9) 3.5 (.9) 3.3 (.8) 3.5 (.8)
WHOQOL Physical 46.4 (21.9) 49.8 (22.3) 54.9 (21.0) 67.3 (21.3) 66.8 (19.2) 67.9 (20.5)
WHOQOL Psychological 61.7 (18.6) 61.4 (21.0) 61.5 (18.8) 66.0 (18.6) 64.9 (15.8) 62.9 (20.1)
WHOQOL Social 63.2 (21.1) 63.8 (21.1) 66.6 (21.0) 64.8 (16.7) 65.0 (16.6) 65.5 (16.1)
WHOQOL Environmental 67.4 (15.1) 68.0 (19.9) 68.0 (16.4) 67.8 (15.9) 70.1 (16.6) 67.4 (17.2)
Note. QOL Quality of Life, WHOQOL World Health Organization Quality of Life BREF version. WHOQOL general is the mean of the Overall QOL and Satisfaction with
health questions on the WHOQOL-BREF. Higher scores suggest better QOL
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0.001, 95% CI 0.24, 0.71). Figure 2 presents the marginal
mean estimates of general QOL in patients and their
partners predicted by the model. Additional file 1 pro-
vides the results of the three-level random intercept
model for changes in general QOL for patients and
partners.
Partners
Results from the linear combination indicated a statisti-
cally significant decline in partners’ general QOL scores
from pre-dialysis to 6 weeks (β = − 0.24, p = 0.04, 95% CI
-0.47, − 0.01). General QOL returned to pre-dialysis
levels at 12 weeks after the patient started dialysis (β = −
0.09, p = 0.47, 95% CI 0.33, 0.15).
Differences between WHOQOL general QOL in patients
and partners
Patients reported significantly lower general QOL at
pre-dialysis compared to their partners (β = 0.72, p <
0.001, 95% CI 0.51, 0.93). At 6 and 12 weeks, general
QOL was not statistically different between patients or
partners (Fig. 2).
Changes in WHOQOL domains
Patients
The patients’ physical domain scores (Fig. 3) significantly
improved between pre-dialysis and 12 weeks after starting
dialysis (β = 6.56, p < 0.004, 95% CI 2.10, 11.03). Within
the physical domain, there was a significant difference in
sleep scores between pre-dialysis and 12 weeks (n = 39,
T1: 2.78 ± 1.08; T3: 3.33 ± 1.11, p = 0.0028). This improve-
ment indicates a change from poor sleep at pre-dialysis to
good sleep at 12 weeks. No other domain scores showed
statistically significant changes (see Figs. 4, 5, 6). In the
psychological domain, scores decreased but still suggest
good QOL. Social and environmental domain scores indi-
cate good QOL, which remained stable over the study.
Additional file 1 provides the results of the three-level ran-
dom intercept models for changes in the domain scores
for patients and partners.
Partners
No statistically significant changes occurred in any QOL
domain (Figs. 3, 4, 5, 6). The physical, social and envir-
onment domain scores were stable and indicate good
QOL. Similar to the patients, the partners’ psychological
domain scores decreased from pre-dialysis to 12 weeks
but reflect good QOL.
Relationship between baseline clinical and socio-
demographic variables and changes in WHOQOL general
QOL
Patients
There were no significant associations between general
QOL and baseline haemoglobin, eGFR, serum albumin,
patient type, mode of dialysis, start of dialysis, or age.
Comorbidity risk level, PRD, access type, and gender ex-
plained variations in the patterns of change in general
Fig. 2 Estimated marginal means of general quality of life scores of patients and partners
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Fig. 3 Estimated marginal means of physical domain scores of patients and partners
Fig. 4 Estimated marginal means of psychological domain scores of patients and partners
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Fig. 5 Estimated marginal means of social domain scores of patients and partners
Fig. 6 Estimated marginal means of environmental domain scores of patients and partners
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Fig. 7 Estimated marginal means of patients’ general quality of life scores by comorbidity risk level
Fig. 8 Estimated marginal means of patients’ general quality of life scores by primary renal diagnosis
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Fig. 9 Estimated marginal means of patients’ general quality of life scores by haemodialysis access type
Fig. 10 Estimated marginal means of patients’ general quality of life scores by gender
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QOL. For comorbidity risk level, there were no signifi-
cant differences in changes in general QOL between pa-
tients with low and medium comorbidity risk. Patients
with a high comorbidity risk had significantly worse gen-
eral QOL at pre-dialysis compared to the low and
medium risk groups (β = − 1.0, p = 0.001, CI -1.61, −
0.39), but their general QOL was not significantly differ-
ent from the low or medium risk groups at 6 and 12
weeks (Fig. 7). Patients with a PRD of diabetes had
poorer QOL at pre-dialysis which did not improve after
starting dialysis which differed to those with other PRDs
(see Fig. 8). In terms of access type in patients planning
to start HD, there were no significant differences in
QOL between patients with AVF or tesio line at pre-
dialysis or 6 weeks (see Fig. 9); however, from pre-dialysis
to 12 weeks, general QOL worsened in patients with a
tesio line compared to those with AVF (β = − 0.98, p =
0.04, CI -1.90, − 0.06). In terms of gender, there were no
significant differences in general QOL between males and
females at pre-dialysis and 6 weeks (see Fig. 10); however,
from pre-dialysis to 12 weeks female patients reported sig-
nificant improvements in general QOL compared to male
patients (β = 0.59, p = 0.03, CI 0.48, 1.13). Additional file 2
shows the results of the two-level random intercept
models for changes in WHOQOL general QOL on the
basis of baseline clinical and socio-demographic variables
in patients and partners.
Partners
There were no significant associations with changes in
general QOL on the basis of age or gender.
Discussion
This study is the first to describe and examine QOL in
patients and their partners as patients transition onto
dialysis. Patients’ general QOL improved over the transi-
tion from pre-dialysis to dialysis, which remained stable
at 12 weeks after starting dialysis. This change marks an
important perceptual shift from poor to good QOL.
Even patients with a high comorbidity risk experienced
significant improvements in general QOL during this
period. However, patients with a PRD of diabetes did
not report improvements in general QOL. Furthermore,
our data show that female patients and patients with
AVF reported significant improvements in their general
QOL compared to male patients or those with tesio
lines. In particular, patients’ physical QOL also improved
from pre-dialysis to 12 weeks, moving from poor to
moderate physical QOL. Within the physical domain,
better sleep quality was the key improvement. In con-
trast, partners reported impaired general QOL after pa-
tients had just started dialysis. However, it had improved
by 12 weeks and returned to a level similar to that re-
ported at the pre-dialysis stage. Partners’ general QOL
remained good throughout the transition period, despite
worsening at 6 weeks. In the psychological, social and
environmental QOL domains, patients and partners re-
ported good QOL, and this remained stable throughout
the transition period.
These findings extend our understanding of changes
in QOL in both members of a couple at the time that a
patient starts dialysis. Importantly, it provides new infor-
mation about what happens to QOL in the critical early
weeks after initiating dialysis. Comparisons with existing
research are difficult to interpret as the only other longi-
tudinal study [21] involving patients and their partners
over the transition onto dialysis administered the SF-36,
which is a measure of health status and functioning ra-
ther than a QOL measure. Consequently, direct compar-
isons between the SF-36 and the WHOQOL-BREF
cannot be made. At pre-dialysis, patients in the present
study only had poor QOL in the general facet and the
physical domain, whereas the patients on PD studied in
Fan et al. [21] reported their physical and mental func-
tioning as poor at this stage. Furthermore, partners in
the present study reported WHOQOL-BREF general
QOL and all domains as good at pre-dialysis, whereas
the partners in Fan et al. [21] reported impaired physical
and mental functioning.
As to the impact of starting dialysis on patients and
their partners, our findings also contrast those reported
by Fan et al. [21]. In the present study patients and their
partners reported changes in their general QOL and pa-
tients’ physical QOL, but in Fan et al. [21] only the social
functioning component of mental health improved after
one year. It is possible that our study might also have
detected a change in the social domain if follow-ups had
been conducted 1 year after starting dialysis. While in-
terpretations across the studies are limited, the present
study’s findings fill an important gap in our knowledge
about the impact of starting dialysis on the QOL of pa-
tients and their partners during the critical first 12
weeks.
Our findings contrast with studies in the wider ESRD
literature, which report patients and partners’ physical
and mental functioning as impaired, as measured by the
SF-36 or SF-12 [28–36]. Our findings differ from the lit-
erature being one of the few studies conducted in the
UK where patients have access to structured pre-dialysis
pathways (i.e., specialist clinics which provide informa-
tion on renal replacement therapy, diet, symptom man-
agement, and lifestyle advice about ESRD to patients and
their families; 50% of patients start dialysis with access
in place [37]). A majority of patients in the present study
started dialysis in a planned manner and had access to
structured pathways and pre-dialysis education, which
are linked with positive patient outcomes [38]. Our find-
ings highlight the need for on-going support to partners
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during the transition onto dialysis to prevent it impair-
ing their QOL at this time.
To our knowledge, only two studies exist which have
used the WHOQOL-BREF in patients with ESRD and
their partners [39, 40]. Our findings indicate that pa-
tients and partners reported good QOL in all domains of
the WHOQOL-BREF at 12 weeks contrasting with stud-
ies by Al-Rawashdeh et al. [40] and Anees et al. [39]. Al-
Rawashdeh et al. conducted a cross-sectional study with
123 Jordanian patients on HD and their partners. Only
partners reported good QOL in every domain, whereas
patients only reported good social QOL. A cross-
sectional study by Anees et al. [39] in Pakistan assessed
125 patients on HD and 50 of their family members.
The partners studied by Anees et al. reported better
QOL in three domains (physical, psychological and so-
cial) than patients whose QOL was poor or moderate in
each of these domains. Comparing patients in the
current study with Anees et al., we conclude that our pa-
tients had better QOL across the domains. Partners in
both studies had similar QOL in the same three do-
mains. However, partners in the present study rated
their environmental QOL better than partners in Anees
et al. These comparisons should be made cautiously as
our UK sample differs in its cultural context, ESRD prac-
tices, and renal service features.
A growing number of studies have used the
WHOQOL-BREF in patient-only samples. These too
were conducted in cultural and renal contexts that may
differ significantly from the UK. One study, conducted
in Korea, used the WHOQOL-BREF with patients in
pre-dialysis care for ESRD [41]. Comparing the pre-
dialysis scores of patients in the two studies, our patients
reported better QOL in the psychological, social and en-
vironment domains, but poorer physical QOL. Other
studies in the field were conducted with patients estab-
lished on dialysis [42–45]. Comparisons with their find-
ings and ours indicate that QOL is similar, although
patients in the present study reported slightly higher
QOL. Similarity between physical QOL in this study and
these others with patients established on dialysis indi-
cates that physical QOL does not continue to improve
as time on dialysis increases. Dialysis only partly
removes the toxins from the body [8]; therefore, im-
provements in physical QOL due to dialysis may only be
noticeable to patients initially.
Only one study by Kang et al. [46], conducted in
Singapore, utilised the WHOQOL-BREF to assess QOL
at baseline and 1 year in 44 partners of patients estab-
lished on PD. Compared to Kang et al., partners in the
current study had similar general QOL, psychological
and social QOL scores but much poorer physical QOL.
The average age of partners in the current study was 63
years (±15 years), whereas in Kang et al. the average was
38 years (±6 years), which may explain the difference in
physical QOL. Interestingly, partners in Kang et al. re-
ported significant impairments in psychological QOL
during the study. In the current study, partners’ psycho-
logical QOL had a downward trend which may indicate
that dialysis and its related stressors have a delayed
negative impact on their QOL. In comparison to other
UK research and in the wider caregiving literature, phys-
ical QOL of the partners in this study are comparable to
those found in healthy participants, whereas psycho-
logical, social and environmental domains of QOL are
more similar to carers of elderly patients [14].
In the present study, we found changes in patients’
general QOL were moderated by comorbidity risk level,
PRD, access type in patients planning to start HD, and
gender. Our findings that poorer QOL was associated
with patients with diabetes and having a tesio line echo
that of the wider literature [8, 47, 48]. However, patients
with a high comorbidity risk reported significant im-
provements to their general QOL that matched the low
and medium risk groups, and female patients reported
their QOL was better than male patients. These findings
differ from that in the ESRD literature where high co-
morbidity and female gender are commonly related to
poor QOL [47, 49]. However, the relationship between
the moderator variables and general QOL should be
interpreted cautiously due to the small sample size and
missing data in four clinical variables (type of patients,
start of dialysis, access type, and PRD) which means very
little information could be used to compute the 6 and
12 week estimates.
Improvements in the patients’ physical QOL scores
was due to better quality sleep. Other studies have found
improvements in sleep quality, assessed the using 3
items forming the sleep domain in the CHEQ instru-
ment; however, only a minority of patients (< 20%) in
these other studies reported better sleep [36, 50]. That
the patients in the current study reported improvements
in their sleep at 12 weeks provides evidence as to when
patients may experience benefits from dialysis.
In this study we selected the WHOQOL-BREF because
it includes a facet on general QOL and items within the
four domains address topics important to patients with
ESRD and their partners. Given the active debate about
how to measure QOL in the ESRD field [12], we ana-
lysed the two items comprising the WHOQOL general
QOL facet as our primary outcome variable. Unlike the
SF-12 and SF-36, they ask participants to rate their over-
all QOL and satisfaction with their health. These two
global items from the WHOQOL general QOL facet
may be a useful indicator for studying QOL at specific
time intervals and between groups [51]. Furthermore,
the four domains of QOL in the WHOQOL-BREF com-
plement the life areas described by Jablonski [5] as being
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affected in the crisis phase. The WHOQOL-BREF also
includes a question on sex-life, which some participants
in the study did not answer. This finding suggests people
may be hesitant to discuss their sex-life, even though it
may be important to their QOL and impacted by ESRD.
This study’s findings offer a new perspective on QOL in
patients and their partners during early dialysis and sug-
gests that there are significant changes in QOL which
warrant further investigation.
A limitation of this study is the small final sample size.
The recruitment period of 1 year yielded a sample of 83
couples. However, due to significant drop-out between
pre-dialysis assessment and subsequent follow-ups, only
39 couples provided data at all three time points. Despite
significant attrition, the only significant difference be-
tween the baseline characteristics of those who dropped
out and those who completed the study was patients’
eGFR. All the patients were deemed to start dialysis
within 2 months, hence the similarity between their
overall symptoms, clinical and biochemical status. There
is little to suggest that patients who completed the study
were any different to those who did not; however, it is
possible that the higher eGFR in those who dropped out
(10.0 vs 8.5) indicates that they felt better in general and
therefore may have been less likely to engage with ESRD
research about starting dialysis. Future studies could
benefit from collecting additional indices on blood, urea,
and nitrogen which may provide a fuller picture of dif-
ferences between patients and changes after starting
dialysis.
Although there was considerable drop-out which ef-
fects overall power, using a random effects MLM
allowed us to utilise all available data at the three time
points which increased the precision of our estimates
[27]. In addition, 93% of the participants were White
British. This homogeneity limits the generalizability of
findings to an ethnically diverse UK population. Follow-
ups at 6 and 12 weeks may have been too soon after
starting dialysis to detect significant changes in all QOL
domains. However, these first 12 weeks are under-
researched. The decision about timing was consolidated
following consultation with a renal research patient-
public involvement group, and participants from a previ-
ous qualitative study.
In this study only patients who were in a spousal-type
relationship and whose partner also consented to take
part were eligible. The wider chronic illness literature
has suggested that recruiting and retaining couples in re-
search requires significant additional time, resources,
and multiple contacts [52]. These issues should be taken
into consideration when designing future couple-based
research in ESRD. Furthermore, when screening poten-
tial patients, we experienced issues identifying those with
a partner as this level of detail is often not routinely
recorded. Although we expected approximately 60% of
patients to have partners, many sites found it to be as
low as 30%. In most renal units, this type of information
is not easily accessible, nor is it monitored at the na-
tional level. Without accessible data about partners, who
are often primary informal caregivers to patients with
ESRD, it is difficult to map an accurate picture of the
caregiving landscape in the ESRD population. Therefore,
we recommend that a mapping exercise is conducted
across UK renal units to more comprehensively describe
this area. Furthermore, we suggest that information on
partners is routinely monitored and reported in a stan-
dardized way.
The major strength of our study is that it focuses on
the changes in QOL during the crisis phase of dialysis.
By zooming in on this time frame, we have exposed the
complex effects of starting dialysis, improving patients’
QOL but initially impairing the QOL of their partners.
At the same time, we demonstrate the need to include
partners in research if we are to better appreciate the
broader impact of treatments. This research provides a
foundation to begin better understanding QOL in pa-
tients and their partners; however, future research with
more couples conducted over a longer time frame may
uncover additional changes that occur as they adjust to
the impact of treatment. Future research which exam-
ines factors which predict changes in QOL could also
offer valuable insight.
Conclusion
Our findings offer encouraging signs that patients’ gen-
eral and physical QOL improve after starting dialysis.
However, it also indicated that patients have impaired
QOL before starting dialysis and that their partners’ gen-
eral QOL diminishes in the initial weeks after the patient
starts dialysis. It is promising that starting dialysis did
not negatively impact the domains of QOL in patients or
their partners.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12882-020-01819-4.
Additional file 1. Results of the multilevel models of changes in QOL in
patients and partners and results from the linear comparison of
parameters analysis in partners.
Additional file 2. Results of the multilevel models of changes in QOL
scores of patients and partners in relation to baseline clinical and socio-
demographic variables.
Abbreviations
AVF: Arteriovenous fistula; CI: Confidence interval; eGFR: Estimated
glomerular filtration rate; ESRD: End stage renal disease; F1: Pre-dialysis to 6
weeks after starting dialysis; F2: Pre-dialysis to 12 weeks after starting dialysis;
HD: Haemodialysis; MLM: Multilevel modelling; NHS: National Health Service;
NIHR: National Institute for Health Research; PD: Peritoneal dialysis;
QOL: Quality of life; SF-12: Short Form Health Survey-12 items; SF-36: Short
Moore et al. BMC Nephrology          (2020) 21:185 Page 16 of 18
Form Health Survey-36 items; SI: Site investigator; T1: Pre-dialysis; T2: 6 weeks;
T3: 12 weeks; WHOQOL-BREF: World Health Organization QOL 26-item
questionnaire
Acknowledgements
Manchester Royal Infirmary’s Renal Patient & Public Involvement Group who
provided invaluable comments on the design and aims of the study; the
renal nursing teams at Manchester University NHS Foundation Trust who
assisted with recruitment; and the 10 research teams who participated in the
study: Manchester University NHS Foundation Trust, Salford Royal
Foundation Trust, Sheffield Teaching Hospital NHS Foundation Trust, York
Teaching Hospital NHS Foundation Trust, Bradford Teaching Hospital NHS
Foundation Trust, Dorset County Hospital NHS Foundation Trust, Queen
Elizabeth Hospital Kings Lynn NHS Trust, Lancashire Teaching Hospitals NHS
Trust, University Hospitals Coventry and Warwick NHS Trust, and Oxford
University Hospitals NHS Foundation Trust.
Authors’ contributions
CM, AW, SS and SM designed the study. CM recruited and collected the data
at Manchester University Foundation Trust and provided training and
oversaw data collection at the other renal units. LAC provided statistical
advice throughout the study. CM and LAC conducted the statistical analyses.
CM drafted the manuscript. All authors (CM, LAC, SS, AW and SM) agreed on
the interpretation of the results, provided meaningful intellectual content,
revised the manuscript and approved the final version.
Authors’ information
Currie Moore, MSc, conducted this study as part of her doctoral candidacy in
the School of Health Sciences & Manchester Centre for Health Psychology at
The University of Manchester.
Lesley-Anne Carter, PhD, is lecturer of Biostatistics in the Division of
Population Health, Health Services Research & Primary Care at The University
of Manchester.
Suzanne Skevington, PhD, is professor of Health Psychology with specialist
interest in quality of life in the Manchester Centre for Health Psychology at
The University of Manchester.
Alison Wearden, PhD, is professor of Health Psychology in the School of
Health Sciences & Manchester Centre for Health Psychology at The University
of Manchester.
Sandip Mitra, MD, is a consultant nephrologist at Manchester University
Hospitals Foundation Trust and Professor of Nephrology at The University of
Manchester.
Funding
This research was funded by the Medical Research Council’s (United
Kingdom) doctoral training partnership PhD studentship and also by the
President’s Doctoral Scholar (University of Manchester) programme awarded
to Currie Moore.
Availability of data and materials
The dataset supporting the conclusions of this article are available from the
corresponding author on reasonable request.
Ethics approval and consent to participate
All participants gave verbal and written informed consent prior to data
collection. Ethical approval was granted by the UK’s Health Research
Authority and NHS North West - Greater Manchester East Research Ethics




The authors declare that they have no competing interests.
Author details
1School of Health Sciences, Division of Psychology and Mental Health,
Manchester Centre for Health Psychology, University of Manchester,
Manchester, UK. 2Manchester Academic Health Science Centre, University of
Manchester, Manchester, UK. 3Division of Population Health, Health Services
Research & Primary Care, University of Manchester, Manchester, UK.
4Manchester University NHS Foundation Trust, Manchester, UK. 5NIHR
Devices for Dignity MedTech Cooperative, Sheffield, UK.
Received: 12 January 2020 Accepted: 19 April 2020
References
1. Morton RL, Devitt J, Howard K, Anderson K, Snelling P, Cass A. Patient views
about treatment of stage 5 CKD: a qualitative analysis of semistructured
interviews. American journal of kidney diseases. 2010;55(3):431-40. PubMed
PMID: 2010591220. Language: English. Entry date: 20100409. Revision date:
20110520. Publication Type: J Article.
2. Morton RL, Tong A, Webster AC, Snelling P, Howard K. Characteristics of
dialysis important to patients and family caregivers: a mixed methods
approach. Nephrol Dial Transplant. 2011;26(12):4038–4046. PubMed PMID:
WOS:000297404000033.
3. Moore C, Majeed-Ariss R, Jayanti A, Mitra S, Skevington S, Wearden A. How
an ordeal becomes the norm: a qualitative exploration of experiences of
self-cannulation in male home haemodialysis patients. Br J Health Psychol
2018 Sep;23(3):544–560. PubMed PMID: 29508505. Epub 2018/03/07. eng.
4. The WHOQOL Group. The development of the WHOQOL. In: Orley J, Kuyken
W, editors. Quality of life assessment: International perspectives. Berlin:
Springer-Verlag; 1994. p. 41–57.
5. Jablonski A. The illness trajectory of end-stage renal disease dialysis patients.
Res Theory Nurs Pract. 2004;18(1):51–72. PubMed PMID: MEDLINE:15083662.
6. Beder J. Evaluation research on the effectiveness of social work intervention
on dialysis patients. Soc Work Health Care. 2000;30(1):15–30.
7. Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, et al.
Psychosocial factors, behavioral compliance and survival in urban
hemodialysis patients. Kidney Int 1998 Jul;54(1):245–254. PubMed PMID:
9648085. Epub 1998/07/02. eng.
8. Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL. Factors
affecting outcomes in patients reaching end-stage kidney disease
worldwide: differences in access to renal replacement therapy, modality
use, and haemodialysis practices. Lancet. 2016;388(10041):294–306.
9. Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL,
et al. Predictors of early mortality among incident US hemodialysis patients
in the Dialysis outcomes and practice patterns study (DOPPS). Clin J Am
Soc Nephrol. 2007;2(1):89–99.
10. Gayomali C, Sutherland S, Finkelstein FO. The challenge for the caregiver of
the patient with chronic kidney disease. Nephrology Dialysis Transplant
2008 Dec;23(12):3749–3751. PubMed PMID: 19028759. Epub 2008/11/26.
eng.
11. Cicolini G, Palma E, Simonetta C, Di Nicola M. Influence of family carers on
haemodialyzed patients' adherence to dietary and fluid restrictions: an
observational study. J Adv Nurs 2012 Nov;68(11):2410–2417. PubMed PMID:
22360845. Epub 2012/03/01. eng.
12. Evangelidis N, Tong A, Manns B, Hemmelgarn B, Wheeler DC, Tugwell P,
et al. Developing a set of core outcomes for trials in hemodialysis: an
international delphi survey. Am J Kidney Dis 2017. Epub 24 Feb 2017.
13. Skevington SM, Lotfy M, O'Connell K. The World Health Organization's
WHOQOL-BREF quality of life assessment: Psychometric properties and
results of the international field trial - A report from the WHOQOL group.
Quality of Life Research. 2004 Mar;13(2):299–310. PubMed PMID: WOS:
000220004500002.
14. Skevington SM, McCrate FM. Expecting a good quality of life in health:
assessing people with diverse diseases and conditions using the WHOQOL-
BREF. Health Expect 2012 Mar;15(1):49–62. PubMed PMID: 21281412.
Pubmed Central PMCID: PMC5060606. Epub 2011/02/02. eng.
15. Urquhart-Secord R, Craig JC, Hemmelgarn B, Tam-Tham H, Manns B, Howell
M, et al. Patient and caregiver priorities for outcomes in hemodialysis: An
international nominal group technique study. Am J Kidney Dis. 2016;68(3):
444–454. PubMed PMID: WOS:000383891000015.
16. Manera KE, Johnson DW, Craig JC, Shen JI, Ruiz L, Wang AY-M, et al. Patient
and caregiver priorities for outcomes in peritoneal dialysis: multinational
nominal group technique study. Clin J Am Soc Nephrol. 2019;14(1):74–83.
17. Moore C, Skevington S, Wearden A, Mitra S. Impact of dialysis on the dyadic
relationship between male patients and their female partners. Qual Health
Res 2019;30(3):1049732319869908. PubMed PMID: 31478450.
Moore et al. BMC Nephrology          (2020) 21:185 Page 17 of 18
18. Monaro S, Stewart G, Gullick J. A 'lost life': Coming to terms with
haemodialysis. Journal of Clinical Nursing. 2014 Nov;23(21–22):3262–73.
PubMed PMID: WOS:000343835300027.
19. Ekelund M-L, Andersson SI. "I need to lead my own life in any case": A study
of patients in dialysis with or without a partner. Patient Education and
Counseling. 2010 Oct;81(1):30–6. PubMed PMID: WOS:000282070900007.
20. Finnegan-John J, Thomas VJ. The psychosocial experience of patients with
end-stage renal disease and its impact on quality of life: Findings from a
needs assessment to shape a service. ISRN Nephrology. 2013 2013;2013:
308986-. PubMed PMID: MEDLINE:24959536.
21. Fan SL, Sathick I, McKitty K, Punzalan S. Quality of life of caregivers and
patients on peritoneal dialysis. Nephrol Dial Transplant 2008;23(5):1713–
1719. PubMed PMID: 18182410.
22. Revenson TA, Griva K, Luszczynska A, Morrison V, Panagopoulou E,
Vilchinsky N, et al. What is caregiving and how should we study it?
Caregiving in the illness context. UK: Palgrave Macmillan; 2016. p. 1–14.
23. Griva K, Goh C, Kang W, Yu Z, Chan M, Wu S, et al. Quality of life and
emotional distress in patients and burden in caregivers: a comparison
between assisted peritoneal dialysis and self-care peritoneal dialysis. Qual
Life Res. 2016;25(2):373–84.
24. Skevington SM, Epton T. How will the sustainable development goals
deliver changes in well-being? A systematic review and meta-analysis to
investigate whether WHOQOL-BREF scores respond to change. BMJ Glob
Health 2018;3(Suppl 1):e000609. PubMed PMID: 29379649. Pubmed Central
PMCID: PMC5759710. Epub 2018/01/31. eng.
25. Diehr PH, Derleth AM, McKenna SP, Martin ML, Bushnell DM, Simon G, et al.
Synchrony of change in depressive symptoms, health status, and quality of
life in persons with clinical depression. Health Qual Life Outcomes. 2006;
4(1):27.
26. Davies SJ, Phillips L, Naish PF, Russell GI. Quantifying comorbidity in
peritoneal dialysis patients and its relationship to other predictors of
survival. Nephrology Dialysis Transplant. 2002 Jun;17(6):1085–1092. PubMed
PMID: 12032201. Epub 2002/05/29. eng.
27. Curran PJ, Obeidat K, Losardo D. Twelve frequently asked questions about
growth curve modeling. J Cogn Dev. 2010;11(2):121–136. PubMed PMID:
PMC3131138.
28. Nagasawa H, Sugita I, Tachi T, Esaki H, Yoshida A, Kanematsu Y, et al. The
relationship between dialysis patients' quality of life and caregivers' quality
of life. Frontiers in Pharmacology. 2018 2018-July-16;9(770). English.
29. Acaray A, Pinar R. Quality of life perceived by chronic haemodialysis patients
and family members. EDTNA/ERCA J 2005;31(1):35–38. PubMed PMID: 16083
026.
30. Rioux JP, Narayanan R, Chan CT. Caregiver burden among nocturnal home
hemodialysis patients. Hemodial Int. 2012 Apr;16(2):214–9. PubMed PMID:
WOS:000302612000005.
31. Gray NA, Zuo L, Hong D, Smyth B, Jun M, De Zoysa J, et al. Quality of life in
caregivers compared with dialysis recipients: the co-ACTIVE sub-study of the
ACTIVE dialysis trial. Nephrology. 2019;24(10):1056–63.
32. Alvarez-Ude F, Valdes C, Estebanez C, Rebollo P. Health-related quality of life
of family caregivers of dialysis patients. Journal of Nephrology. 2004 Nov-
Dec;17(6):841–50. PubMed PMID: WOS:000225744100015.
33. Celik G, Annagur BB, Yilmaz M, Demir T, Kara F. Are sleep and life quality of
family caregivers affected as much as those of hemodialysis patients? Gen
Hosp Psychiatry 2012;34(5):518–524. PubMed PMID: 22401704. Epub 2012/
03/10. eng.
34. Belasco A, Barbosa D, Bettencourt AR, Diccini S, Sesso R. Quality of life of
family caregivers of elderly patients on hemodialysis and peritoneal dialysis.
Am J Kidney Dis 2006;48(6):955–963. PubMed PMID: 17162150.
35. Shimoyama S, Hirakawa O, Yahiro K, Mizumachi T, Schreiner A, Kakuma T.
Health-related quality of life and caregiver burden among peritoneal dialysis
patients and their family caregivers in Japan. Peritoneal Dialysis
International. 2003 2003;23:S200-S5. PubMed PMID: WOS:000188533200042.
36. Wu AW, Fink NE, Marsh-Manzi JVR, Meyer KB, Finkelstein FO, Chapman MM,
et al. Changes in quality of life during hemodialysis and peritoneal dialysis
treatment: Generic and disease specific measures. Journal of the American
Society of Nephrology. 2004 Mar;15(3):743–53. PubMed PMID: WOS:
000189218800026.
37. Registry UR. UK renal Registry 21st annual report - data to 31/12/2017. UK:
Bristol; 2019.
38. Rivara MB, Mehrotra R. Timing of dialysis initiation: What has changed since
IDEAL? Seminars in Nephrology. 2017;37(2):181–93. PubMed PMID:
28410652. eng.
39. Anees M, Hameed F, Mumtaz A, Ibrahim M, Khan MNS. Dialysis-related
factors affecting quality of life in patients on hemodialysis. Iran J Kidney Dis.
2011;5(1):9–14. PubMed PMID: WOS:000297128600002.
40. Al-Rawashdeh S, Alshraifeen A, Rababa M, Ashour A. Hope predicted quality
of life in dyads of community-dwelling patients receiving hemodialysis and
their family caregivers. Qual Life Res. 2020 January 01;29(1):81–9.
41. Lee YJ, Kim MS, Cho S, Kim SR. Association of depression and anxiety with
reduced quality of life in patients with predialysis chronic kidney disease.
International Journal of Clinical Practice. 2013 Apr;67(4):363–8. PubMed
PMID: WOS:000316749400012.
42. Griva K, Kang AW, Yu ZL, Mooppil NK, Foo M, Chan CM, et al. Quality of life
and emotional distress between patients on peritoneal dialysis versus
community-based hemodialysis. Quality of Life Research. 2014 Feb;23(1):57–
66. PubMed PMID: WOS:000330831100008.
43. Ginieri-Coccossis M, Theofilou P, Synodinou C, Tomaras V, Soldatos C.
Quality of life, mental health and health beliefs in haemodialysis and
peritoneal dialysis patients: Investigating differences in early and later years
of current treatment. BMC Nephrology. 2008 2008;9. PubMed PMID: WOS:
000207664700014.
44. Griva K, Yu Z, Chan S, Krisnasamy T, Abu Yamin RB, Zakaria FB, et al. Age is
not a contraindication to home-based dialysis - Quality-of-Life outcomes
favour older patients on peritoneal dialysis regimes relative to younger
patients. J Adv Nurs. 2014 Aug;70(8):1902–1914. PubMed PMID: WOS:
000339492500021.
45. Tsai Y-C, Hung C-C, Hwang S-J, Wang S-L, Hsiao S-M, Lin M-Y, et al. Quality
of life predicts risks of end-stage renal disease and mortality in patients with
chronic kidney disease. Nephrol Dial Transplant. 2010;25(5):1621–1626.
PubMed PMID: WOS:000276994400045.
46. Kang A, Yu Z, Foo M, Chan CM, Griva K. Evaluating burden and quality of
life among caregivers of patients receiving peritoneal dialysis. Peritoneal
Dialysis Int. 2019;39(2):176–80.
47. Zyoud SeH, Daraghmeh DN, Mezyed DO, Khdeir RL, Sawafta MN, Ayaseh
NA, et al. Factors affecting quality of life in patients on haemodialysis: a
cross-sectional study from Palestine. BMC Nephrology. 2016 2016/04/27;
17(1):44.
48. Pei M, Aguiar R, Pagels AA, Heimbürger O, Stenvinkel P, Bárány P, et al.
Health-related quality of life as predictor of mortality in end-stage renal
disease patients: an observational study. BMC Nephrology. 2019;20(1):144.
49. Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT,
et al. Quality of life over time in dialysis: The Netherlands Cooperative Study
on the Adequacy of Dialysis. Kidney International. 1999 Aug;56(2):720–8.
PubMed PMID: WOS:000081601200039.
50. Unruh ML, Buysse DJ, Dew MA, Evans IV, Wu AW, Fink NE, et al. Sleep
quality and its correlates in the first year of dialysis. Clin J Am Soc Nephrol.
2006;1(4):802–10.
51. Sloan JA, Aaronson N, Cappelleri JC, Fairclough DL, Varricchio C, Group
CSCM, editors. Assessing the clinical significance of single items relative to
summated scores. Mayo Clinic Proceedings; 2002: Elsevier.
52. Revenson TA, Griva K, Luszczynska A, Morrison V, Panagopoulou E,
Vilchinsky N, et al. Caregiving as a dyadic process. Caregiving in the illness
context. Basingstoke: Palgrave Macmillan. 2016:25–37.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Moore et al. BMC Nephrology          (2020) 21:185 Page 18 of 18
